Navigation Links
Appistry Chief Scientific Officer to Speak at Inaugural Conference on Delivering Genome-Enabled Diagnostics in the Clinic
Date:9/23/2013

St. Louis, MO (PRWEB) September 23, 2013

Appistry, Inc., a leading provider of high-performance computing and analytics solutions for next-generation medicine and the authorized distributor of select genetic analysis tools from the Broad Institute, today announced its chief scientific officer, Dr. Richard Mazzarella, will deliver a presentation titled “Clinical Best Practices for Cancer Genetic Analysis Pipelines,” at Cambridge HealthTech Institute’s inaugural Clinical Genomics for Cancer Diagnostics Conference in Boston Sept. 23-24 at the Seaport Hotel. In his presentation, which will kick off the “Data Interpretation” conference track on Sept. 24, Mazzarella will illustrate how the use of de facto standard genetic analysis tools enables labs to commit more bioinformatics resources to more challenging and less well-understood pipeline development tasks.

“Genetic analysis is a rapidly changing field, but certain tools are emerging as best practices because they have been used in a wide range of studies and in large-scale efforts such as The Cancer Genome Atlas and the International Cancer Genome Consortium,” Mazzarella said. “Running pipelines based on these validated tools conserves development effort for those analysis tasks that require truly innovative approaches and more extensive evaluation.”

Appistry, a sponsor of the conference, will also exhibit its software solutions geared toward helping clinical labs take their next-generation sequencing (NGS) pipelines into production. As an exhibitor at booth number 7, Appistry will share with conference attendees the challenges of implementing NGS sequencing in clinical labs in the context of its computing environment, Ayrris™. The technology applies computing capabilities developed for the analysis of “big data” in sectors such as finance and defense to the analysis of genetic data and the development of next-generation medicine.

The Clinical Genomics for Cancer Diagnostics Conference will examine novel diagnostic tools and techniques, evaluate their benefit to patient outcome, and focus on steps to implementation. The two-day event will gather leaders in cancer genomics, bioinformatics, clinical genomics, pharmacogenomics, diagnostics, internal medicine, molecular biology, and translational research.

Following the conference, Appistry will also host a webinar featuring the latest pipeline and tools for cancer genetic analysis from the Broad Institute. The one-hour webinar titled “Which Mutations Matter: Analyzing and Annotating Cancer Genomes,” will take place on Oct. 3, 2013 at 12 p.m. EDT. For more information and to register for the free event, please visit appistry.com/webinar.

About Appistry
Appistry (http://www.appistry.com) orchestrates solutions to big data problems and since 2001, Appistry’s fabric technology has empowered organizations and researchers to transform vast data into actionable intelligence. Appistry leverages its fabric computing technology to power Ayrris™, a big-data environment that weaves together high performance computing and analytics to provide the throughput and scale required for diverse applications—from discovering new medical therapies to delivering overnight packages, gaining clarity from financial transactions, or deciphering military satellite images. Appistry is the authorized distributor of the GATK and select genetic analysis tools from the Broad Institute for use in for-profit settings. For the latest Appistry news, visits us on Facebook, Twitter and LinkedIn.

Read the full story at http://www.prweb.com/releases/2013/9/prweb11148047.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Arecor Appoints Dr. Sarah Howell as Chief Operating Officer
2. John Saltamartine to Lead Operations as VR Laboratories Chief Operating Officer
3. Ambit Biosciences Names Michael A. Martino President and Chief Executive Officer
4. Rhythm Names Lex Van der Ploeg Chief Scientific Officer
5. Biocartis Names Dr. Nayan Gregory Parekh As Chief Executive Officer
6. Immune Design Corp. Appoints Wayne R. Gombotz, Ph.D. as Chief Development Officer
7. AFFiRiS AG Invests Into Human Capital - Chief Business Officer Recruited
8. Codexis Names Wes Bolsen VP and Chief Marketing Officer
9. Zyngenia, Inc. Promotes Chief Scientific Officer and Hires Chief Business Officer
10. Synergy Pharmaceuticals, Inc. Files Suit Against Ironwood Pharmaceuticals, Inc. and its Chief Scientific Officer and Senior VP of R&D, Dr. Mark G. Currie
11. GenVec President and Chief Executive Officer Announces Retirement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... SAN DIEGO , June 24, 2016 /PRNewswire/ ... that more sensitively detects cancers susceptible to PARP ... individual circulating tumor cells (CTCs). The new test ... of HRD-targeted therapeutics in multiple cancer types. ... therapies targeting DNA damage response pathways, including PARP, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... Researchers at ... most commonly-identified miRNAs in people with peritoneal or pleural mesothelioma. Their findings are the ... read it now. , Diagnostic biomarkers are signposts in the blood, lung fluid ...
(Date:6/23/2016)... ... June 23, 2016 , ... UAS LifeSciences, one of the ... brand, UP4™ Probiotics, into Target stores nationwide. The company, which has been manufacturing ... to its list of well-respected retailers. This list includes such fine stores as ...
(Date:6/23/2016)... 23, 2016 /PRNewswire/ - FACIT has announced the ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or ... of a portfolio of first-in-class WDR5 inhibitors for ... as WDR5 represent an exciting class of therapies, ... medicine for cancer patients. Substantial advances have been ...
Breaking Biology Technology:
(Date:4/15/2016)... , April 15, 2016 ... the,  "Global Gait Biometrics Market 2016-2020,"  report to ... http://photos.prnewswire.com/prnh/20160330/349511LOGO ) , ,The global gait biometrics ... of 13.98% during the period 2016-2020. ... angles, which can be used to compute factors ...
(Date:4/13/2016)... CHICAGO , April 13, 2016  IMPOWER physicians ... are setting a new clinical standard in telehealth ... By leveraging the higi platform, IMPOWER patients can ... weight, pulse and body mass index, and, when they ... quick and convenient visit to a local retail location ...
(Date:3/31/2016)... 31, 2016  Genomics firm Nabsys has completed a ... Barrett Bready , M.D., who returned to the company ... technical leadership team, including Chief Technology Officer, John ... Steve Nurnberg and Vice President of Software and Informatics, ... Dr. Bready served as CEO of Nabsys ...
Breaking Biology News(10 mins):